Contamination of dry powder inhalers for asthma with milk proteins containing lactose.
Nowak-Wegrzyn
Anna
A
Shapiro
Gail G
GG
Beyer
Kirsten
K
Bardina
Ludmila
L
Sampson
Hugh A
HA
D000280:Administration, Inhalation; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology; D000707:Anaphylaxis / Q000209:etiology; D000730:Androstadienes / Q000009:adverse effects / Q000276:immunology; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000276:immunology; D002648:Child; D004338:Drug Combinations; D004340:Drug Contamination; D000068297:Fluticasone-Salmeterol Drug Combination; D006801:Humans; D007785:Lactose / Q000032:analysis / Q000276:immunology; D008297:Male; D016269:Milk Hypersensitivity / Q000150:complications / Q000276:immunology; D008894:Milk Proteins / Q000032:analysis / Q000276:immunology*; D011208:Powders
D000730:Androstadienes; D001993:Bronchodilator Agents; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D008894:Milk Proteins; D011208:Powders; D007785:Lactose; D000420:Albuterol